Onconova Therapeutics: Q1 Earnings Insights

Onconova Therapeutics ONTX reported its Q1 earnings results on Monday, May 15, 2023 at 04:18 PM.

Here's what investors need to know about the announcement.

Earnings

Onconova Therapeutics beat estimated earnings by 6.67%, reporting an EPS of $-0.28 versus an estimate of $-0.3.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.02 which was followed by a 1.91% increase in the share price the next day.

Here's a look at Onconova Therapeutics's past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -0.28 -0.21 -0.21 -0.19
EPS Actual -0.26 -0.26 -0.19 -0.20
Revenue Estimate 60K 60K 60K 80K
Revenue Actual 56K 57K 57K 56K

To track all earnings releases for Onconova Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!